日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors

一项针对晚期实体瘤的双硫仑、铜和长春瑞滨的安全性和有效性的 1b 期开放标签、剂量递增研究

Eefsen, Rikke Løvendahl; Stenvang, Jan; Bartek, Jiri; Pfeiffer, Per; Tarpgaard, Line; Theile, Susann; Brünner, Nils; Nielsen, Dorte L

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.

吉西他滨和白蛋白紫杉醇治疗不可切除胰腺癌患者肿瘤中 ABCG2 蛋白的表达

Shim Susy, Nielsen Mette Bak, Eld Mikkel, Stenvang Jan, Brøndum Rasmus Froberg, Weber Britta, Motavaf Anne Krejbjerg, Ladekarl Morten

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer

PANTAX:一项针对不可切除或转移性胰腺癌的Ib期临床试验,研究外排泵抑制剂SCO-101联合吉西他滨和白蛋白紫杉醇的疗效。

Shim, Susy; Reinacher-Schick, Anke; Kraeft, Anna-Lena; Per Pfeiffer; Tarpgaard, Line Schmidt; Ettrich, Thomas Jens; Kestler, Angelika; Christensen, Signe; Jandu, Haatisha; Nawabi, Mubeen; Roest, Nicklas Lindland; Damstrup, Lars; Vestlev, Peter Michael; Brünner, Nils; Stenvang, Jan; Ladekarl, Morten

Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer

SCO-101通过抑制ABCG2增强化疗在癌症治疗中的疗效

Anamarija Pfeiffer ,Luca Di Leo ,Marc Baker Bechmann ,Mubeen Nawabi ,Sophie Ambjørner ,Diba Ardeshir-Larijani ,Louise Thybo Colstrup ,Signe Vedel Borchert ,Lasse Saaby ,Birger Brodin ,Michael Gajhede ,Xamuel Loft Lund ,Martina Čečková ,Nils Brünner ,Jan Stenvang

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells

恒定链 CD74 蛋白是乳腺癌细胞中 TIMP-1 的细胞表面结合伙伴

Mikkel Høeberg, Julie Boertmann Noer, Mette Vixø Vistesen, Annette Bartels, Esben Matzen Bech, Sune Boris Nygård, Ulrik Lademann, Jan Stenvang, Siqi Liu, Anja Thoe Fuglsang, Nils Brünner, José Manuel Afonso Moreira

Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer

靶向滋养层细胞表面抗原2 (Trop-2) 的抗体药物偶联物 (ADC) 和乳腺癌的精准治疗

Stenvang, Jan; Vestlev, Peter Michael; Jensen, Benny Vittrup; Pfeiffer, Per

Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock

从澳大利亚沙漠植物 Eremophila galeata Chinnock 中分离的 5,3',5'-三羟基-3,6,7,4'-四甲氧基黄酮可逆转 ABCG2/BCRP 介导的多药耐药性

Malene J Petersen, Xamuel L Lund, Susan J Semple, Bevan Buirchell, Henrik Franzyk, Michael Gajhede, Kenneth T Kongstad, Jan Stenvang, Dan Staerk

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

一项全面的 RNA 研究旨在识别乳腺癌多西他赛耐药性的 circRNA 和 miRNA 生物标志物

Huang Peide, Li Fengyu, Mo Zongchao, Geng Chunyu, Wen Fang, Zhang Chunyan, Guo Jia, Wu Song, Li Lin, Brünner Nils, Stenvang Jan

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance

多西他赛耐药前列腺癌细胞的分子分析确定了多种治疗耐药机制

Thiago S Lima, Diego Iglesias-Gato, Luciano D O Souza, Jan Stenvang, Diego S Lima, Martin A Røder, Klaus Brasso, José M A Moreira

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

吡唑并[3,4-d]嘧啶衍生物 SCO-201 可逆转 ABCG2/BCRP 介导的多药耐药性

Sophie E B Ambjørner, Michael Wiese, Sebastian Christoph Köhler, Joen Svindt, Xamuel Loft Lund, Michael Gajhede, Lasse Saaby, Birger Brodin, Steffen Rump, Henning Weigt, Nils Brünner, Jan Stenvang